AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$3.58
+0.00 (+0.00%)
As of May 16, 9:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
144.02M
Net Income
146.2K
Gross Margin
99.1%
Profit Margin
0.1%
Rev Growth
+5.2%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.1% 99.1% 42.9% 42.9%
Operating Margin 70.5% 63.5% -12.1% -11.8%
Profit Margin 0.1% 0.1% -13.6% -13.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 144.02M 136.88M 22.23M 24.20M
Gross Profit 142.74M 135.66M 9.53M 10.37M
Operating Income 101.59M 86.90M -2,685,737 -2,845,163
Net Income 146.2K 125.1K -3,026,461 -3,348,387
Gross Margin 99.1% 99.1% 42.9% 42.9%
Operating Margin 70.5% 63.5% -12.1% -11.8%
Profit Margin 0.1% 0.1% -13.6% -13.8%
Rev Growth +5.2% +5.2% +14.5% +15.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 20.91M 20.91M 13.67M 12.56M
Total Equity 50.71M 50.71M 33.53M 40.20M
D/E Ratio 0.41 0.41 0.41 0.31
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 111.17M 100.37M -4,014,681 -4,691,998
Free Cash Flow -2,971,274 -2,303,520